10-K Filing

AGILON HEALTH, INC. CIK: 1831097 FY 2021

Filing Information

Form Type	10-K
Accession Number	`0000950170-22-002826`
Period End Date	20211231
Filing Date	20220303
Fiscal Year	2021
Fiscal Period	FY
XBRL Instance	agl-20211231_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 73 Income Statement 73 Cash Flow Statement 127 Stockholders Equity 36

Balance Sheet 73 line items

Line Item	Tag	Value	Unit	Period
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$106.80M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$1.04B	USD	Point-in-time
Restricted cash and equivalents	`RestrictedCashEquivalentsCurrent`	$28.38M	USD	Point-in-time
Restricted cash and equivalents	`RestrictedCashEquivalentsCurrent`	$14.78M	USD	Point-in-time
Receivables, net	`ReceivablesNetCurrent`	$144.56M	USD	Point-in-time
Receivables, net	`ReceivablesNetCurrent`	$293.41M	USD	Point-in-time
Prepaid expenses and other current assets, net	`PrepaidExpenseAndOtherAssetsCurrent`	$9.64M	USD	Point-in-time
Prepaid expenses and other current assets, net	`PrepaidExpenseAndOtherAssetsCurrent`	$18.97M	USD	Point-in-time
Redeemable common stock, par value	`TemporaryEquityParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Current assets held for sale and discontinued operations, net	`AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent`	$4.83M	USD	Point-in-time
Temporary Equity, Shares Issued	`TemporaryEquitySharesIssued`	76.20M	shares	Point-in-time
Current assets held for sale and discontinued operations, net	`AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent`	-	USD	Point-in-time
Total current assets	`AssetsCurrent`	$1.37B	USD	Point-in-time
Total current assets	`AssetsCurrent`	$294.20M	USD	Point-in-time
Temporary Equity, Shares Outstanding	`TemporaryEquitySharesOutstanding`	76.20M	shares	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$9.16M	USD	Point-in-time
Common Stock, Par or Stated Value Per Share	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$6.46M	USD	Point-in-time
Common Stock, Par or Stated Value Per Share	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Common Stock, Shares Authorized	`CommonStockSharesAuthorized`	500.00M	shares	Point-in-time
Common Stock, Shares Authorized	`CommonStockSharesAuthorized`	2.00B	shares	Point-in-time
Intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$60.47M	USD	Point-in-time
Intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$55.40M	USD	Point-in-time
Goodwill	`Goodwill`	$41.54M	USD	Point-in-time
Common Stock, Shares, Issued	`CommonStockSharesIssued`	249.37M	shares	Point-in-time
Common Stock, Shares, Issued	`CommonStockSharesIssued`	400.10M	shares	Point-in-time
Goodwill	`Goodwill`	$41.54M	USD	Point-in-time
Other assets, net	`OtherAssetsNoncurrent`	$112.96M	USD	Point-in-time
Common Stock, Shares, Outstanding	`CommonStockSharesOutstanding`	249.37M	shares	Point-in-time
Other assets, net	`OtherAssetsNoncurrent`	$43.70M	USD	Point-in-time
Common Stock, Shares, Outstanding	`CommonStockSharesOutstanding`	400.10M	shares	Point-in-time
Total assets	`Assets`	$446.36M	USD	Point-in-time
Assets	`Assets`	$446.36M	USD	Point-in-time
Total assets	`Assets`	$1.59B	USD	Point-in-time
Assets	`Assets`	$1.59B	USD	Point-in-time
Liabilities	`Liabilities`	$421.59M	USD	Point-in-time
Liabilities	`Liabilities`	$494.66M	USD	Point-in-time
Medical claims and related payables	`LiabilityForClaimsAndClaimsAdjustmentExpense`	$162.87M	USD	Point-in-time
Medical claims and related payables	`LiabilityForClaimsAndClaimsAdjustmentExpense`	$239.01M	USD	Point-in-time
Accounts payable and accrued expenses	`AccountsPayableAndAccruedLiabilitiesCurrent`	$112.95M	USD	Point-in-time
Accounts payable and accrued expenses	`AccountsPayableAndAccruedLiabilitiesCurrent`	$97.24M	USD	Point-in-time
Current portion of long-term debt	`LongTermDebtCurrent`	$3.04M	USD	Point-in-time
Current portion of long-term debt	`LongTermDebtCurrent`	$5.00M	USD	Point-in-time
Current liabilities held for sale and discontinued operations	`LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent`	$3.68M	USD	Point-in-time
Current liabilities held for sale and discontinued operations	`LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent`	-	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$266.83M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$356.96M	USD	Point-in-time
Long-term debt, net of current portion	`LongTermDebtNoncurrent`	$43.40M	USD	Point-in-time
Long-term debt, net of current portion	`LongTermDebtNoncurrent`	$64.67M	USD	Point-in-time
Other liabilities	`OtherLiabilitiesNoncurrent`	$90.09M	USD	Point-in-time
Other liabilities	`OtherLiabilitiesNoncurrent`	$94.30M	USD	Point-in-time
Total liabilities	`Liabilities`	$421.59M	USD	Point-in-time
Total liabilities	`Liabilities`	$494.66M	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Contingently redeemable common stock, $0.01 par value: 76,201 shares issued and outstanding at December 31, 2020	`TemporaryEquityCarryingAmountAttributableToParent`	-	USD	Point-in-time
Contingently redeemable common stock, $0.01 par value: 76,201 shares issued and outstanding at December 31, 2020	`TemporaryEquityCarryingAmountAttributableToParent`	$309.50M	USD	Point-in-time
Common stock, $0.01 par value: 2,000,000 and 500,000 shares authorized; 400,095 and 249,374 shares issued and outstanding, respectively	`CommonStockValue`	$4.00M	USD	Point-in-time
Common stock, $0.01 par value: 2,000,000 and 500,000 shares authorized; 400,095 and 249,374 shares issued and outstanding, respectively	`CommonStockValue`	$2.49M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$2.05B	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$263.97M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-551.19M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-957.68M	USD	Point-in-time
Total agilon health, inc. stockholders' equity (deficit)	`StockholdersEquity`	$-284.73M	USD	Point-in-time
Total agilon health, inc. stockholders' equity (deficit)	`StockholdersEquity`	$1.09B	USD	Point-in-time
Noncontrolling interests	`MinorityInterest`	$-300.00K	USD	Point-in-time
Noncontrolling interests	`MinorityInterest`	-	USD	Point-in-time
Total stockholders equity (deficit)	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.09B	USD	Point-in-time
Total stockholders equity (deficit)	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-232.03M	USD	Point-in-time
Total stockholders equity (deficit)	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-284.73M	USD	Point-in-time
Total stockholders equity (deficit)	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$41.60M	USD	Point-in-time
Total liabilities, contingently redeemable common stock and stockholders equity (deficit)	`LiabilitiesAndStockholdersEquity`	$1.59B	USD	Point-in-time
Total liabilities, contingently redeemable common stock and stockholders equity (deficit)	`LiabilitiesAndStockholdersEquity`	$446.36M	USD	Point-in-time

Income Statement 73 line items

Line Item	Tag	Value	Unit	Period
General And Administrative Including Non Cash Stock-based Compensation Expense	`AllocatedShareBasedCompensationExpense`	$4.40M	USD	Annual
General And Administrative Including Non Cash Stock-based Compensation Expense	`AllocatedShareBasedCompensationExpense`	$6.47M	USD	Annual
General And Administrative Including Non Cash Stock-based Compensation Expense	`AllocatedShareBasedCompensationExpense`	$2.60M	USD	Point-in-time
General And Administrative Including Non Cash Stock-based Compensation Expense	`AllocatedShareBasedCompensationExpense`	$292.39M	USD	Annual
Total revenues	`RevenueFromContractWithCustomerExcludingAssessedTax`	$1.83B	USD	Annual
Total revenues	`RevenueFromContractWithCustomerExcludingAssessedTax`	$1.22B	USD	Annual
Total revenues	`RevenueFromContractWithCustomerExcludingAssessedTax`	$794.41M	USD	Annual
Medical services expense	`PolicyholderBenefitsAndClaimsIncurredHealthCare`	$1.02B	USD	Annual
Medical services expense	`PolicyholderBenefitsAndClaimsIncurredHealthCare`	$725.37M	USD	Annual
Medical services expense	`PolicyholderBenefitsAndClaimsIncurredHealthCare`	$1.65B	USD	Annual
Other medical expenses	`OtherMedicalExpenses`	$102.31M	USD	Annual
Other medical expenses	`OtherMedicalExpenses`	$109.49M	USD	Annual
Other medical expenses	`OtherMedicalExpenses`	$40.53M	USD	Annual
General and administrative	`GeneralAndAdministrativeExpense`	$137.29M	USD	Annual
General and administrative	`GeneralAndAdministrativeExpense`	$455.82M	USD	Annual
General and administrative	`GeneralAndAdministrativeExpense`	$122.83M	USD	Annual
Depreciation and amortization	`DepreciationAndAmortization`	$12.25M	USD	Annual
Depreciation and amortization	`DepreciationAndAmortization`	$14.54M	USD	Annual
Depreciation and amortization	`DepreciationAndAmortization`	$13.53M	USD	Annual
Total expenses	`OperatingExpenses`	$2.23B	USD	Annual
Total expenses	`OperatingExpenses`	$1.28B	USD	Annual
Total expenses	`OperatingExpenses`	$900.99M	USD	Annual
Income (loss) from operations	`OperatingIncomeLoss`	$-56.67M	USD	Annual
Income (loss) from operations	`OperatingIncomeLoss`	$-393.95M	USD	Annual
Income (loss) from operations	`OperatingIncomeLoss`	$-106.57M	USD	Annual
Other income (expense), net	`NonoperatingIncomeExpense`	$955.00K	USD	Annual
Other income (expense), net	`NonoperatingIncomeExpense`	$2.46M	USD	Annual
Other income (expense), net	`NonoperatingIncomeExpense`	$-4.50M	USD	Annual
Interest expense	`InterestExpense`	$8.13M	USD	Annual
Interest expense	`InterestExpense`	$6.15M	USD	Annual
Interest expense	`InterestExpense`	$9.07M	USD	Annual
Income (loss) before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-114.69M	USD	Annual
Income (loss) before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-404.60M	USD	Annual
Income (loss) before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-62.34M	USD	Annual
Income tax benefit (expense)	`IncomeTaxExpenseBenefit`	$886.00K	USD	Annual
Income tax benefit (expense)	`IncomeTaxExpenseBenefit`	$865.00K	USD	Annual
Income tax benefit (expense)	`IncomeTaxExpenseBenefit`	$-232.00K	USD	Annual
Income (loss) from continuing operations	`IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest`	$-405.48M	USD	Annual
Income (loss) from continuing operations	`IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest`	$-114.45M	USD	Annual
Income (loss) from continuing operations	`IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest`	$-63.21M	USD	Annual
Income (loss) before impairments, gain (loss) on sales and income taxes	`DiscontinuedOperationsIncomeLossBeforeImpairmentsGainLossOnSalesAndIncomeTaxes`	$-86.11M	USD	Annual
Income (loss) before impairments, gain (loss) on sales and income taxes	`DiscontinuedOperationsIncomeLossBeforeImpairmentsGainLossOnSalesAndIncomeTaxes`	$-3.46M	USD	Annual
Income (loss) before impairments, gain (loss) on sales and income taxes	`DiscontinuedOperationsIncomeLossBeforeImpairmentsGainLossOnSalesAndIncomeTaxes`	$-20.05M	USD	Annual
Impairments	`DiscontinuedOperationImpairmentsCharges`	-	USD	Annual
Impairments	`DiscontinuedOperationImpairmentsCharges`	$98.34M	USD	Annual
Impairments	`DiscontinuedOperationImpairmentsCharges`	-	USD	Annual
Gain (loss) on sales of assets, net	`DiscontinuedOperationGainLossOnSaleOfAssetsNet`	$20.40M	USD	Annual
Gain (loss) on sales of assets, net	`DiscontinuedOperationGainLossOnSaleOfAssetsNet`	$473.00K	USD	Annual
Gain (loss) on sales of assets, net	`DiscontinuedOperationGainLossOnSaleOfAssetsNet`	-	USD	Annual
Income tax benefit (expense)	`DiscontinuedOperationTaxEffectOfDiscontinuedOperation`	$-1.69M	USD	Annual
Income tax benefit (expense)	`DiscontinuedOperationTaxEffectOfDiscontinuedOperation`	$-16.17M	USD	Annual
Income tax benefit (expense)	`DiscontinuedOperationTaxEffectOfDiscontinuedOperation`	$-2.80M	USD	Annual
Total discontinued operations	`IncomeLossFromDiscontinuedOperationsNetOfTax`	$-168.28M	USD	Annual
Total discontinued operations	`IncomeLossFromDiscontinuedOperationsNetOfTax`	$-1.30M	USD	Annual
Total discontinued operations	`IncomeLossFromDiscontinuedOperationsNetOfTax`	$3.16M	USD	Annual
Net income (loss)	`ProfitLoss`	$-60.05M	USD	Annual
Net income (loss)	`ProfitLoss`	$-406.79M	USD	Annual
Net income (loss)	`ProfitLoss`	$-282.74M	USD	Annual
Noncontrolling interests' share in (earnings) loss	`NetIncomeLossAttributableToNoncontrollingInterest`	$-300.00K	USD	Annual
Noncontrolling interests' share in (earnings) loss	`NetIncomeLossAttributableToNoncontrollingInterest`	-	USD	Annual
Noncontrolling interests' share in (earnings) loss	`NetIncomeLossAttributableToNoncontrollingInterest`	$-152.00K	USD	Annual
Net income (loss) attributable to common shares	`NetIncomeLoss`	$-406.49M	USD	Annual
Net income (loss) attributable to common shares	`NetIncomeLoss`	$-60.05M	USD	Annual
Net income (loss) attributable to common shares	`NetIncomeLoss`	$-282.59M	USD	Annual
Continuing operations	`IncomeLossFromContinuingOperationsPerBasicAndDilutedShare`	$-1.09	USD	Annual
Continuing operations	`IncomeLossFromContinuingOperationsPerBasicAndDilutedShare`	$-0.20	USD	Annual
Continuing operations	`IncomeLossFromContinuingOperationsPerBasicAndDilutedShare`	$-0.39	USD	Annual
Discontinued operations	`IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicAndDilutedShare`	-	USD	Annual
Discontinued operations	`IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicAndDilutedShare`	$0.01	USD	Annual
Discontinued operations	`IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicAndDilutedShare`	$-0.57	USD	Annual
Weighted average shares outstanding, basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	323.46M	shares	Annual
Weighted average shares outstanding, basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	294.74M	shares	Annual
Weighted average shares outstanding, basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	372.93M	shares	Annual

Cash Flow Statement 127 line items

Line Item	Tag	Value	Unit	Period
Net income (loss)	`ProfitLoss`	$-60.05M	USD	Annual
Net income (loss)	`ProfitLoss`	$-406.79M	USD	Annual
Net income (loss)	`ProfitLoss`	$-282.74M	USD	Annual
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$41.41M	USD	Annual
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$14.67M	USD	Annual
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$14.10M	USD	Annual
Stock-based compensation expense	`ShareBasedCompensation`	$5.22M	USD	Annual
Stock-based compensation expense	`ShareBasedCompensation`	$292.39M	USD	Annual
Stock-based compensation expense	`ShareBasedCompensation`	$6.69M	USD	Annual
Loss on debt extinguishment	`GainsLossesOnExtinguishmentOfDebt`	-	USD	Annual
Loss on debt extinguishment	`GainsLossesOnExtinguishmentOfDebt`	$-1.59M	USD	Annual
Loss on debt extinguishment	`GainsLossesOnExtinguishmentOfDebt`	-	USD	Annual
Loss (income) from equity method investments	`IncomeLossFromEquityMethodInvestments`	$-747.00K	USD	Annual
Loss (income) from equity method investments	`IncomeLossFromEquityMethodInvestments`	$514.00K	USD	Annual
Loss (income) from equity method investments	`IncomeLossFromEquityMethodInvestments`	$-6.77M	USD	Annual
Loss (income) from equity method investments	`IncomeLossFromEquityMethodInvestments`	$8.90M	USD	1 Quarter
Deferred income taxes and uncertain tax positions	`DeferredIncomeTaxesAndUncertainTaxPositions`	$16.18M	USD	Annual
Deferred income taxes and uncertain tax positions	`DeferredIncomeTaxesAndUncertainTaxPositions`	$3.23M	USD	Annual
Deferred income taxes and uncertain tax positions	`DeferredIncomeTaxesAndUncertainTaxPositions`	$2.81M	USD	Annual
Release of indemnification assets	`FDICIndemnificationAssetNetWriteOffs`	$-3.48M	USD	Annual
Release of indemnification assets	`FDICIndemnificationAssetNetWriteOffs`	$-1.71M	USD	Annual
Release of indemnification assets	`FDICIndemnificationAssetNetWriteOffs`	$-19.22M	USD	Annual
Impairments	`ImpairmentOfLongLivedAssetsToBeDisposedOf`	-	USD	Annual
Impairments	`ImpairmentOfLongLivedAssetsToBeDisposedOf`	-	USD	Annual
Impairments	`ImpairmentOfLongLivedAssetsToBeDisposedOf`	$98.34M	USD	Annual
(Gain) loss on sale of assets, net	`GainLossOnDispositionOfAssets1`	$20.40M	USD	Annual
(Gain) loss on sale of assets, net	`GainLossOnDispositionOfAssets1`	-	USD	Annual
(Gain) loss on sale of assets, net	`GainLossOnDispositionOfAssets1`	$473.00K	USD	Annual
Distributions of earnings from equity method investments	`DistributionsOfEarningsFromEquityMethodInvestments`	$-174.00K	USD	Annual
Distributions of earnings from equity method investments	`DistributionsOfEarningsFromEquityMethodInvestments`	-	USD	Annual
Distributions of earnings from equity method investments	`DistributionsOfEarningsFromEquityMethodInvestments`	-	USD	Annual
Other non-cash items	`OtherNoncashIncomeExpense`	$3.07M	USD	Annual
Other non-cash items	`OtherNoncashIncomeExpense`	$162.00K	USD	Annual
Other non-cash items	`OtherNoncashIncomeExpense`	$-58.00K	USD	Annual
Receivables, net	`IncreaseDecreaseInReceivables`	$23.28M	USD	Annual
Receivables, net	`IncreaseDecreaseInReceivables`	$59.38M	USD	Annual
Receivables, net	`IncreaseDecreaseInReceivables`	$149.04M	USD	Annual
Prepaid expense and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$565.00K	USD	Annual
Prepaid expense and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$3.92M	USD	Annual
Prepaid expense and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$5.08M	USD	Annual
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$-2.42M	USD	Annual
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$-3.93M	USD	Annual
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$1.98M	USD	Annual
Medical claims and related payables	`IncreaseDecreaseInMedicalClaimsAndRelatedPayables`	$-76.34M	USD	Annual
Medical claims and related payables	`IncreaseDecreaseInMedicalClaimsAndRelatedPayables`	$-19.81M	USD	Annual
Medical claims and related payables	`IncreaseDecreaseInMedicalClaimsAndRelatedPayables`	$-42.38M	USD	Annual
Accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$18.45M	USD	Annual
Accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$19.36M	USD	Annual
Accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$24.92M	USD	Annual
Other liabilities	`IncreaseDecreaseInOtherOperatingLiabilities`	$-1.70M	USD	Annual
Other liabilities	`IncreaseDecreaseInOtherOperatingLiabilities`	$5.61M	USD	Annual
Other liabilities	`IncreaseDecreaseInOtherOperatingLiabilities`	$16.34M	USD	Annual
Net cash provided by (used in) operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-53.20M	USD	Annual
Net cash provided by (used in) operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-148.16M	USD	Annual
Net cash provided by (used in) operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-103.86M	USD	Annual
Purchase of property and equipment, net	`PaymentsToAcquirePropertyPlantAndEquipment`	$1.77M	USD	Annual
Purchase of property and equipment, net	`PaymentsToAcquirePropertyPlantAndEquipment`	$6.56M	USD	Annual
Purchase of property and equipment, net	`PaymentsToAcquirePropertyPlantAndEquipment`	$2.89M	USD	Annual
Purchase of intangible assets, net	`PaymentsToAcquireIntangibleAssets`	$1.01M	USD	Annual
Purchase of intangible assets, net	`PaymentsToAcquireIntangibleAssets`	$575.00K	USD	Annual
Purchase of intangible assets, net	`PaymentsToAcquireIntangibleAssets`	$6.86M	USD	Annual
Investments in loans receivable and other	`PaymentsToAcquireLoansReceivable`	$1.15M	USD	Annual
Investments in loans receivable and other	`PaymentsToAcquireLoansReceivable`	$3.85M	USD	Annual
Investments in loans receivable and other	`PaymentsToAcquireLoansReceivable`	$82.83M	USD	Annual
Proceeds from repayment of loans receivable and other	`ProceedsFromCollectionOfLoansReceivable`	$7.09M	USD	Annual
Proceeds from repayment of loans receivable and other	`ProceedsFromCollectionOfLoansReceivable`	-	USD	Annual
Proceeds from repayment of loans receivable and other	`ProceedsFromCollectionOfLoansReceivable`	$2.06M	USD	Annual
Proceeds from sale of business and property, net of cash divested	`ProceedsFromDivestitureOfBusinessesNetOfCashDivested`	$26.20M	USD	Annual
Proceeds from sale of business and property, net of cash divested	`ProceedsFromDivestitureOfBusinessesNetOfCashDivested`	$-1.34M	USD	Annual
Proceeds from sale of business and property, net of cash divested	`ProceedsFromDivestitureOfBusinessesNetOfCashDivested`	-	USD	Annual
Net cash provided by (used in) investing activities	`NetCashProvidedByUsedInInvestingActivities`	$22.07M	USD	Annual
Net cash provided by (used in) investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-90.51M	USD	Annual
Net cash provided by (used in) investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-5.06M	USD	Annual
Proceeds from initial public offering	`ProceedsFromIssuanceInitialPublicOffering`	$1.17B	USD	Annual
Proceeds from initial public offering	`ProceedsFromIssuanceInitialPublicOffering`	-	USD	Annual
Proceeds from initial public offering	`ProceedsFromIssuanceInitialPublicOffering`	-	USD	Annual
Proceeds from equity issuances, net	`ProceedsFromIssuanceOfCommonStock`	$33.59M	USD	Annual
Proceeds from equity issuances, net	`ProceedsFromIssuanceOfCommonStock`	-	USD	Annual
Proceeds from equity issuances, net	`ProceedsFromIssuanceOfCommonStock`	$180.19M	USD	Annual
Proceeds from exercise of stock options	`ProceedsFromStockOptionsExercised`	$814.00K	USD	Annual
Proceeds from exercise of stock options	`ProceedsFromStockOptionsExercised`	$18.09M	USD	Annual
Proceeds from exercise of stock options	`ProceedsFromStockOptionsExercised`	-	USD	Annual
Repurchase of shares, net	`PaymentsForRepurchaseOfEquity`	-	USD	Annual
Repurchase of shares, net	`PaymentsForRepurchaseOfEquity`	-	USD	Annual
Repurchase of shares, net	`PaymentsForRepurchaseOfEquity`	$6.74M	USD	Annual
Proceeds from the issuance of long-term debt	`ProceedsFromIssuanceOfLongTermDebt`	$100.00M	USD	Annual
Proceeds from the issuance of long-term debt	`ProceedsFromIssuanceOfLongTermDebt`	-	USD	Annual
Proceeds from the issuance of long-term debt	`ProceedsFromIssuanceOfLongTermDebt`	-	USD	Annual
Repayments of long-term borrowings and other	`RepaymentsOfLongTermDebt`	$119.90M	USD	Annual
Repayments of long-term borrowings and other	`RepaymentsOfLongTermDebt`	$3.59M	USD	Annual
Repayments of long-term borrowings and other	`RepaymentsOfLongTermDebt`	$3.04M	USD	Annual
Equity and debt issuance costs and other	`PaymentsOfDebtIssuanceCosts`	$14.74M	USD	Annual
Equity and debt issuance costs and other	`PaymentsOfDebtIssuanceCosts`	-	USD	Annual
Equity and debt issuance costs and other	`PaymentsOfDebtIssuanceCosts`	-	USD	Annual
Distribution to noncontrolling interests	`PaymentsToMinorityShareholders`	-	USD	Annual
Distribution to noncontrolling interests	`PaymentsToMinorityShareholders`	$303.00K	USD	Annual
Distribution to noncontrolling interests	`PaymentsToMinorityShareholders`	-	USD	Annual
Net cash provided by (used in) financing activities	`NetCashProvidedByUsedInFinancingActivities`	$176.30M	USD	Annual
Net cash provided by (used in) financing activities	`NetCashProvidedByUsedInFinancingActivities`	$24.62M	USD	Annual
Net cash provided by (used in) financing activities	`NetCashProvidedByUsedInFinancingActivities`	$1.15B	USD	Annual
Net increase (decrease) in cash, cash equivalents and restricted cash and equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect`	$67.38M	USD	Annual
Net increase (decrease) in cash, cash equivalents and restricted cash and equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect`	$-6.52M	USD	Annual
Net increase (decrease) in cash, cash equivalents and restricted cash and equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect`	$915.73M	USD	Annual
Cash, cash equivalents and restricted cash and equivalents from continuing operations, beginning of year	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$76.41M	USD	Point-in-time
Cash, cash equivalents and restricted cash and equivalents from continuing operations, beginning of year	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$135.18M	USD	Point-in-time
Cash, cash equivalents and restricted cash and equivalents from continuing operations, beginning of year	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$1.05B	USD	Point-in-time
Cash, cash equivalents and restricted cash and equivalents from continuing operations, beginning of year	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$139.15M	USD	Point-in-time
Cash, cash equivalents and restricted cash and equivalents from discontinued operations, beginning of year	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations`	-	USD	Point-in-time
Cash, cash equivalents and restricted cash and equivalents from discontinued operations, beginning of year	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations`	$3.92M	USD	Point-in-time
Cash, cash equivalents and restricted cash and equivalents from discontinued operations, beginning of year	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations`	$6.46M	USD	Point-in-time
Cash, cash equivalents and restricted cash and equivalents from discontinued operations, beginning of year	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations`	$1.82M	USD	Point-in-time
Cash, cash equivalents and restricted cash and equivalents, beginning of year	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$145.61M	USD	Point-in-time
Cash, cash equivalents and restricted cash and equivalents, beginning of year	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$78.23M	USD	Point-in-time
Cash, cash equivalents and restricted cash and equivalents, beginning of year	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$1.05B	USD	Point-in-time
Cash, cash equivalents and restricted cash and equivalents, beginning of year	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$139.09M	USD	Point-in-time
Cash, cash equivalents and restricted cash and equivalents from continuing operations, end of year	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$76.41M	USD	Point-in-time
Cash, cash equivalents and restricted cash and equivalents from continuing operations, end of year	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$135.18M	USD	Point-in-time
Cash, cash equivalents and restricted cash and equivalents from continuing operations, end of year	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$1.05B	USD	Point-in-time
Cash, cash equivalents and restricted cash and equivalents from continuing operations, end of year	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$139.15M	USD	Point-in-time
Cash, cash equivalents and restricted cash and equivalents from discontinued operations, end of year	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations`	-	USD	Point-in-time
Cash, cash equivalents and restricted cash and equivalents from discontinued operations, end of year	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations`	$3.92M	USD	Point-in-time
Cash, cash equivalents and restricted cash and equivalents from discontinued operations, end of year	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations`	$6.46M	USD	Point-in-time
Cash, cash equivalents and restricted cash and equivalents from discontinued operations, end of year	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations`	$1.82M	USD	Point-in-time
Cash, cash equivalents and restricted cash and equivalents, end of year	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$145.61M	USD	Point-in-time
Cash, cash equivalents and restricted cash and equivalents, end of year	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$78.23M	USD	Point-in-time
Cash, cash equivalents and restricted cash and equivalents, end of year	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$1.05B	USD	Point-in-time
Cash, cash equivalents and restricted cash and equivalents, end of year	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$139.09M	USD	Point-in-time

Stockholders Equity 36 line items

Line Item	Tag	Value	Unit	Period
Beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.09B	USD	Point-in-time
Beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-232.03M	USD	Point-in-time
Beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-284.73M	USD	Point-in-time
Beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$41.60M	USD	Point-in-time
Beginning balance, shares	`CommonStockSharesOutstanding`	249.37M	shares	Point-in-time
Beginning balance, shares	`CommonStockSharesOutstanding`	400.10M	shares	Point-in-time
Contingently Redeemable Common Stock, Beginning balance, shares	`TemporaryEquitySharesOutstanding`	76.20M	shares	Point-in-time
Contingently Redeemable Common Stock, Beginning balance	`TemporaryEquityCarryingAmountAttributableToParent`	-	USD	Point-in-time
Contingently Redeemable Common Stock, Beginning balance	`TemporaryEquityCarryingAmountAttributableToParent`	$309.50M	USD	Point-in-time
Net income (loss)	`ProfitLoss`	$-60.05M	USD	Annual
Net income (loss)	`ProfitLoss`	$-406.79M	USD	Annual
Net income (loss)	`ProfitLoss`	$-282.74M	USD	Annual
Issuance of common stock, shares	`StockIssuedDuringPeriodSharesNewIssues`	11.70M	shares	Point-in-time
Issuance of common stock, shares	`StockIssuedDuringPeriodSharesNewIssues`	1.20M	shares	Annual
Issuance of common stock, value	`StockIssuedDuringPeriodValueNewIssues`	$5.55M	USD	Annual
Issuance of contingently redeemable common stock	`IssuanceOfContingentlyRedeemableCommonStockValue`	$-460.00K	USD	Annual
Issuance of contingently redeemable common stock	`IssuanceOfContingentlyRedeemableCommonStockValue`	$-806.00K	USD	Annual
Settlement of stock-based liabilities	`AdjustmentsToAdditionalPaidInCapitalSettlementOfStockBasedLiabilities`	$1.50M	USD	Annual
Settlement of stock-based liabilities	`AdjustmentsToAdditionalPaidInCapitalSettlementOfStockBasedLiabilities`	$5.00M	USD	Annual
Repurchase of common stock	`StockRepurchasedDuringPeriodValue`	$6.74M	USD	Annual
Repurchase of common stock, shares	`StockRepurchasedDuringPeriodShares`	1.50M	shares	Annual
Exercises and vesting of stock-based awards	`StockIssuedDuringPeriodValueStockOptionsExercised`	$18.09M	USD	Annual
Exercises and vesting of stock-based awards	`StockIssuedDuringPeriodValueStockOptionsExercised`	$814.00K	USD	Annual
Stock-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$23.93M	USD	Annual
Stock-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$5.22M	USD	Annual
Stock-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$6.69M	USD	Annual
Distribution to noncontrolling interests	`MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders`	$303.00K	USD	Annual
Contingently Redeemable Common Stock, Ending balance, shares	`TemporaryEquitySharesOutstanding`	76.20M	shares	Point-in-time
Contingently Redeemable Common Stock, Ending balance	`TemporaryEquityCarryingAmountAttributableToParent`	-	USD	Point-in-time
Contingently Redeemable Common Stock, Ending balance	`TemporaryEquityCarryingAmountAttributableToParent`	$309.50M	USD	Point-in-time
Ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.09B	USD	Point-in-time
Ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-232.03M	USD	Point-in-time
Ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-284.73M	USD	Point-in-time
Ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$41.60M	USD	Point-in-time
Ending balance, shares	`CommonStockSharesOutstanding`	249.37M	shares	Point-in-time
Ending balance, shares	`CommonStockSharesOutstanding`	400.10M	shares	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.